Initiation of mRNA translation in oncogenesis: The role of eIF4E

Cell Cycle

Volumn 3, Issue 11, 2004, Pages 1387-1389

  Montanaro, Lorenzo ^b   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

Apoptosis; c Myc; Cancer; eIF4E; mRNA translation; Ribosome; Senescence

Indexed keywords

BINDING PROTEIN; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHATIDYLINOSITOL KINASE 3; PROTEIN KINASE B; RAF PROTEIN; RAPAMYCIN; RAS PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BINDING AFFINITY; CARCINOGENESIS; GENE CONTROL; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; ONCOGENE C MYC; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTO ONCOGENE; RIBOSOME; RNA TRANSLATION; SENESCENCE; SHORT SURVEY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 14644405512     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.11.1251     Document Type: Short Survey

References (18)

1. Mathews MB, Sonenberg N, Hershey JWB. Origins and principles of translational control. In: Sonenberg N, Hershey JWB, Mathews MB, eds. Translational control of gene expression. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 2000:1-31.
2. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15:807-26.
3. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N. eIF4E - from translation to transformation. Oncogene 2004; 23:3172-9.
4. Kozak M. The scanning model for translation: An update. J Cell Biol 1989; 108:229-241.
5. Jackson RJ. A comparative view of initiation site selection mechanisms. In: Sonenberg N, Hershey JWB, Mathews MB, eds. Translational control of gene expression. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 2000:127-183.
6. Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22:2954-63.
7. Bjornsti MA, Houghton PJ. The TOR pathway: A target for cancer therapy. Nat Rev Cancer. 2004; 4:335-48.
8. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Genes Dev 1999; 68:913-63.
9. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23:3189-99.
10. De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE. Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F. Mol Cell Biol 1991; 11:5435-45.
11. Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. J Biol Chem 2004; 279:3327-39.
12. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990; 345:544-7.
13. Lazaris-Karatzas A, Sonenberg N. The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 1992; 12:1234-8.
14. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation iactor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 2004; 10:484-6.
15. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318:533-8.
16. Rajasekhar VK, Holland EC. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 2004; 23:3248-64.
17. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004; 428:332-7.
18. Pandolfi PP. Aberrant mRNA translation in cancer pathogenesis: An old concept revisited comes finally of age. Oncogene 2004; 23:3134-7.